These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 18610759)

  • 21. Glitazones in chronic kidney disease: potential and concerns.
    Bolignano D; Zoccali C
    Nutr Metab Cardiovasc Dis; 2012 Mar; 22(3):167-75. PubMed ID: 22364889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Triple oral therapy for type 2 diabetes.
    Bell DS
    Diabetes Res Clin Pract; 2007 Dec; 78(3):313-5. PubMed ID: 17320237
    [No Abstract]   [Full Text] [Related]  

  • 23. Research profile. Warding off type 2. Can taking glitazones cut the risk? Philip A. Kern, MD.
    Kordella T
    Diabetes Forecast; 2003 Jun; 56(6):113-5. PubMed ID: 15858895
    [No Abstract]   [Full Text] [Related]  

  • 24. [Chronic kidney disease and antidiabetic treatment].
    Berwert L; Teta D; Zanchi A
    Rev Med Suisse; 2007 Mar; 3(101):598-604. PubMed ID: 17436798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thiazolidinediones.
    Edelman SV
    N Engl J Med; 2005 Jan; 352(2):205-7; author reply 205-7. PubMed ID: 15651124
    [No Abstract]   [Full Text] [Related]  

  • 26. Point: Recent long-term clinical studies support an enhanced role for thiazolidinediones in the management of type 2 diabetes.
    Kahn SE; Zinman B
    Diabetes Care; 2007 Jun; 30(6):1672-6. PubMed ID: 17351271
    [No Abstract]   [Full Text] [Related]  

  • 27. [Diagnosis, implication, prevention and treatment of microalbuminuria].
    Schmieder RE; Bramlage P
    Dtsch Med Wochenschr; 2012 Jul; 137(27):1409-16; quiz 1417-8. PubMed ID: 22736183
    [No Abstract]   [Full Text] [Related]  

  • 28. Choosing first-line therapy for management of type 2 diabetes.
    Graber MA; Darby-Stewart A; Dachs R
    Am Fam Physician; 2008 Jan; 77(1):16-7. PubMed ID: 18236820
    [No Abstract]   [Full Text] [Related]  

  • 29. [New subgroup analysis of the PROactive Study. Risk for recurrent stroke cut in half].
    MMW Fortschr Med; 2006 Oct; 148(41):50-1. PubMed ID: 17190265
    [No Abstract]   [Full Text] [Related]  

  • 30. The therapeutic efficacy of rosiglitazone is enhanced in sulphonylurea-treated patients with type 2 diabetes.
    Itakura H; Abbasi F; Lamendola C; Basina M; Reaven G
    Diabetes Obes Metab; 2008 Aug; 10(8):685-7. PubMed ID: 18476981
    [No Abstract]   [Full Text] [Related]  

  • 31. Cardiovascular risk and cardiometabolic protection: role of glitazones.
    Petrazzi L; Grassi D; Polidoro L; D'Aurelio A; Croce G; Properzi G; Tiberti S; Desideri G; Ferri C
    J Nephrol; 2008; 21(6):826-35. PubMed ID: 19034866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Positive and negative effects of glitazones in carcinogenesis: experimental models vs. clinical practice.
    Bojková B; Orendáš P; Kubatka P; Péč M; Kassayová M; Kisková T; Kajo K
    Pathol Res Pract; 2014 Aug; 210(8):465-72. PubMed ID: 25023882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Introduction: beyond glycemic control in type 2 diabetes.
    Barnett AH
    Curr Med Res Opin; 2006; 22 Suppl 2():S1-4. PubMed ID: 16914070
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical implications of the DREAM Study.
    Davidson MB
    Diabetes Care; 2007 Feb; 30(2):418-20. PubMed ID: 17259522
    [No Abstract]   [Full Text] [Related]  

  • 35. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: update regarding thiazolidinediones: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.
    Nathan DM; Buse JB; Davidson MB; Ferrannini E; Holman RR; Sherwin R; Zinman B
    Diabetes Care; 2008 Jan; 31(1):173-5. PubMed ID: 18165348
    [No Abstract]   [Full Text] [Related]  

  • 36. [Glitazone - mailing no 1. In response to DMW 49/2007].
    Traut V
    Dtsch Med Wochenschr; 2008 Feb; 133(6):261; author reply 262-3. PubMed ID: 18236356
    [No Abstract]   [Full Text] [Related]  

  • 37. [Glitazone - mailing no 3. In response to DMW 49/2007].
    Gundel UF
    Dtsch Med Wochenschr; 2008 Feb; 133(6):261-2; author reply 262-3. PubMed ID: 18236354
    [No Abstract]   [Full Text] [Related]  

  • 38. Renal Evaluation and Protection.
    Amir R; Suhl S; Alexander CM
    Clin Geriatr Med; 2020 Aug; 36(3):431-445. PubMed ID: 32586473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Kidney and glitazones].
    Deray G; Izzedine H; Launay-Vacher V; Bagnis C
    Ann Endocrinol (Paris); 2005 Apr; 66(2 Pt 2):1S81-90. PubMed ID: 15959407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 30 things you should know about managing diabetes.
    Bunker K
    Diabetes Forecast; 2008 Apr; 61(4):54-6. PubMed ID: 18478645
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.